Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

BTOG 2024 | BTOG 2024 insights & future directions: a comprehensive approach to thoracic malignancies

Sanjay Popat, from The Royal Marsden NHS Foundation Trust in London, UK, shares his enthusiasm for the BTOG 2024 congress in Belfast, UK, which gathered over a thousand delegates. The meeting emphasized the comprehensive approach to managing primary thoracic malignancies, with representation from various disciplines including respiratory physicians, medical oncologists, surgeons, and more. Prof. Popat highlights BTOG’s commitment to providing equitable and optimal care through education, research, facilitation, and representation. He encourages registration for membership, offering access to CPD accredited educational materials and specialist events. The upcoming agenda includes webinars updating on international meetings outcomes and essential updates on mesothelioma and stage IV malignancies treatment paradigms. Notably, BTOG introduces a research group to foster structured academic drug trials research. Prof. Popat looks forward to reconvening at BTOG 2025 for another enriching meeting. This interview took place at the BTOG 2024 congress in Belfast, UK.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.